Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

After Fresh Lifetime Highs, Where Next For Biotech Funds?
Barron's
Saturday, August 4, 2012 - 12:44pm
tags:
Merck & Co Inc (MRK): Today's Featured Drugs Winner
The Steet
Saturday, August 4, 2012 - 12:15pm
tags:
Merck
Dividends On Sale: The Big Drop In Bristol-Myers Is Worth Buying
Seeking Alpha
Saturday, August 4, 2012 - 12:15pm
tags:
Bristol-Myers Squibb
Pipeline Setback at Bristol-Myers
Yahoo/Zacks
Saturday, August 4, 2012 - 12:14pm
tags:
Bristol-Myers Squibb, BMS-986094, hepatitis C, INX-189
Investors are Myopic on Johnson & Johnson’s Prospects
Motley Fool
Saturday, August 4, 2012 - 12:13pm
tags:
JNJ
US FDA approves first generic versions of Merck's Singulair
Reuters
Saturday, August 4, 2012 - 12:12pm
tags:
Merck, Singulair, generics
Eli Lilly: Strong Cash Flows And Undervalued Pipeline
Seeking Alpha
Saturday, August 4, 2012 - 12:11pm
tags:
Eli Lilly, earnings, pipelines
SurModics Beats on All Fronts
Yahoo/Zacks
Saturday, August 4, 2012 - 12:08pm
tags:
SurModics
Why Regeneron May Not Profit Much From Today's FDA Approval
Forbes
Saturday, August 4, 2012 - 12:07pm
tags:
Regeneron, Zaltrap, colorectal cancer
Earnings Preview: Vivus
Seeking Alpha
Saturday, August 4, 2012 - 11:33am
tags:
Vivus, earnings
9 Rallying Healthcare Stocks Seeing Strong Sales Trends
Seeking Alpha
Saturday, August 4, 2012 - 11:32am
tags:
Cynosure, Human Genome Sciences, Alexion, Watson, The Medicines Company, Gilead Sciences, Medtox, Trinity Biotech
4 Small-Cap Biotech Stocks Generating Profits With Buy Ratings
Seeking Alpha
Saturday, August 4, 2012 - 11:30am
tags:
Exelixis, Spectrum Pharmaceuticals, ViroPharma, Momenta
PDL BioPharma's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Seeking Alpha
Saturday, August 4, 2012 - 11:29am
tags:
PDL Biopharma, earnings
A Strong Week for Gilead
Motley Fool
Saturday, August 4, 2012 - 11:28am
tags:
Gilead Sciences
Agenus' CEO Discusses Q2 2012 Results - Earnings Call Transcript
Seeking Alpha
Saturday, August 4, 2012 - 11:27am
tags:
Agenus, earnings
Novavax takes bigger 2Q loss as costs grow
Yahoo/AP
Saturday, August 4, 2012 - 11:26am
tags:
Novavax, earnings
Sarepta Therapeutics gets stop work order from US defense dept
Reuters
Saturday, August 4, 2012 - 11:24am
tags:
Sarepta, ebola virus
Momenta Loses In Appeals Court Over Watson’s Lovenox Copy
Bloomberg
Saturday, August 4, 2012 - 11:23am
tags:
Momenta, Lovenox, Watson, generics, lawsuits
Medivation and Astellas Announce PDUFA Action Date for Enzalutamide NDA
Yahoo/MarketWire
Saturday, August 4, 2012 - 11:22am
tags:
Medivation, Astellas, Enzalutamide, prostate cancer
Bad News for ViroPharma
Yahoo/Zacks
Saturday, August 4, 2012 - 11:20am
tags:
ViroPharma, Halozyme, Cinryze, rHuPH20

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.